Literature DB >> 9233640

Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex.

B Ghebrehiwet1, P D Lu, W Zhang, S A Keilbaugh, L E Leigh, P Eggleton, K B Reid, E I Peerschke.   

Abstract

Two types of widely coexpressed, highly acidic, cell membrane binding proteins that display preferential domain specificity for C1q have been described: a 60-kDa calreticulin homologue, designated cC1q-R, that binds to the collagen-like "stalk" and a 33-kDa glycoprotein with affinity for the globular "heads" (gC1q-R). Although the two molecules are known to be coexpressed on all cell types examined to date and often coelute during purification, there is no direct evidence showing that they associate with each other either on the membrane or when examined in a purified system. In this report we present the first evidence that 1) biotinylated cC1q-R binds to recombinant as well as native gC1q-R, as assessed by solid phase ELISA; 2) binding sites for cC1q-R are located within N-terminal residues 76 through 93 of the mature form of gC1q-R and within residues 204 through 218; 3) this interaction is inhibited by two mAbs, 60.11 and 46.23, that recognize primarily epitopes within the N terminus of gC1q-R corresponding to residues 74 through 96 and by mAb 74.5.2 that recognizes epitopes within residues 204 through 218; and 4) biotinylated cC1q-R binds to microtiter-fixed Raji and K562 cells, and this interaction is inhibited by mAb 60.11. Furthermore, coimmunoprecipitation analysis of Raji cell membranes with anti-gC1q-R mAbs showed the presence of cC1q-R in addition to gC1q-R. Taken together, the evidence suggests that cC1q-R is able to form a complex with gC1q-R and may associate with gC1q-R on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233640

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms.

Authors:  L E Leigh; B Ghebrehiwet; T P Perera; I N Bird; P Strong; U Kishore; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Authors:  D J Kittlesen; K A Chianese-Bullock; Z Q Yao; T J Braciale; Y S Hahn
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Authors:  S K Petersen-Mahrt; C Estmer; C Ohrmalm; D A Matthews; W C Russell; G Akusjärvi
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

Review 5.  Inside-Out of Complement in Cancer.

Authors:  Martin Kolev; Madhumita Das; Monica Gerber; Scott Baver; Pascal Deschatelets; Maciej M Markiewski
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 6.  An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.

Authors:  Carlos Alejandro Egusquiza-Alvarez; Martha Robles-Flores
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-20       Impact factor: 4.322

7.  T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis.

Authors:  K Jiang; Y Chen; C-S Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria.

Authors:  Lijuan Xu; Nengming Xiao; Feng Liu; Hongwei Ren; Jun Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

9.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 10.  Context-dependent roles of complement in cancer.

Authors:  Lubka T Roumenina; Marie V Daugan; Florent Petitprez; Catherine Sautès-Fridman; Wolf Herman Fridman
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.